American Herbal Products Association (AHPA) > News > Alerts

Alerts

  News   >   Alerts

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

IADSA update on international supplement regulations

IADSA March 2017 Newsflash

This issue of the IADSA Newsflash includes an update on China publishing a list of the forms and sources of vitamins and minerals that can be used as health food raw materials and its draft health food filing guidance.

AHPA Issues Guidance on Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Materials

AHPA members have volunteered to apply the portions of the guidance document relevant to their operations

The American Herbal Products Association (AHPA) is developing an assessment program for its recently adopted Guidance on Good Agricultural and Collection Practices (GACP) and Good Manufacturing Practices for Botanical Materials.

AHPA NDI Database shows 15 of 59 most recent NDI notifications acknowledged by FDA without objection

18 NDI notifications were considered incomplete

Fifteen (or roughly 25 percent) of the 59 New Dietary Ingredient (NDI) notifications submitted to the Food and Drug Administration (FDA) between November 2015 and October 2016 were acknowledged without objection, according to the latest data uploaded to AHPA's NDI Database.

Labeling guidance for fungi products

Guidance becomes effective March 9, 2019

The Board of Trustees of the American Herbal Products Association (AHPA) at its March 9, 2017 meeting authorized issuance of guidance for labeling products that contain fungi ingredients.
AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA and the entire herbal products industry have greatly benefited from their years of dedication and hard work

The American Herbal Products Association (AHPA) presented its 2017 awards to Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals for substantive and positive contributions to the herbal products industry

AHPA expresses support for synthetic cannabinoids being placed into schedule I

February 2017: AHPA submits comments to DEA

The American Herbal Products Association (AHPA) expressed strong support for the Drug Enforcement Agency (DEA) using its temporary scheduling authority to place synthetic cannabinoids into schedule I in comments submitted to the agency.

IADSA update on international supplement regulations

IADSA December 2016 Newsflash

This issue of the IADSA Newsflash includes an update on the Association of Southeast Asian Nations (ASEAN) Agreement on Regulatory Framework for Health Supplements deadline for implementation, which will be pushed back to March 2023.

AHPA submits comments to FDA on revised NDI draft guidance

December 2016: Draft NDI guidance fails to achieve FDA's stated goals and is contrary to intent of the law

In comments submitted to the Food and Drug Administration (FDA), the American Herbal Products Association (AHPA) expressed concern that the latest revision of draft guidance for New Dietary Ingredients (NDIs) is unlikely to achieve FDA's stated goals and is contrary to the intent of the law in numerous areas.

AHPA submits comments to DEA on potential impacts of scheduling herbal constituents

December 2016: DEA should avoid restricting research on new medical uses, health benefits, or other uses for botanicals

In comments submitted last week to the Drug Enforcement Agency (DEA), the American Herbal Products Association (AHPA) urged the agency to refrain from using its authority to effectively remove a plant from the existing marketplace because naturally occurring constituents become scheduled under the Controlled Substances Act (CSA).

AHPA submits comments to FTC regarding consumer perceptions of "organic" claims

December 2016: Many personal care products and dietary supplements are produced in compliance with USDA's National Organic Progam

AHPA stressed that non-food products, including personal care products, may be agricultural products that can comply with the United States Department of Agriculture (USDA) National Organic Program (NOP).
RSS
First 14151617181920212223 Last

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.

          
Address: 8630 Fenton Street, Suite 918, Silver Spring, MD 20910
Phone: 301.588.1171
Email: ahpa@ahpa.org
©Copyright 2022 AHPA
Copyright 2024 by American Herbal Products Association (AHPA) | Privacy Statement | Terms Of Use